During the past decade, Massachusetts General Hospital Heart Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Massachusetts General Hospital Heart Center" #1 collaborator was "ActiGraph LLC" with 1 trials as a collaborator, "Almac Clinical Technologies" with 1 trials as a collaborator, "Beth Israel Deaconess Medical Center" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator and "Covance" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Massachusetts General Hospital Heart Center" are "Atherosclerosis" (1 trials), "Cardiovascular Diseases" (1 trials), "Congenital Heart Disease" (1 trials), "Congenital Heart Disease With Fontan Circulation" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "Massachusetts General Hospital Heart Center" in a lesser frequency.

Most popular intervention types in "Massachusetts General Hospital Heart Center" are "Drug" (3 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "ABIOMED, Inc. hemodynamic support devices" (1 trials), "Dual Antiplatelet (DAPT) Therapy" (1 trials), "Macitentan 10 mg" (1 trials), "Placebo" (1 trials) and "The Synergy® stent" (1 trials). Other intervention names were less common.

The vast majority of trials in "Massachusetts General Hospital Heart Center" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Massachusetts General Hospital Heart Center". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Massachusetts General Hospital Heart Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Massachusetts General Hospital Heart Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".